Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.

Also called NCT02289963

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 199 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02289963
Other papers using this trial's data
  • A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT) Journal of clinical lipidology, 2018 DOI, PubMed 29153823
  • A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab Journal of the Chinese Medical Association : JCMA, 2019-04 DOI, PubMed 30946207

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
South Korea, Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02289963. Randomized; quadruple masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2016-04 (actual). Results posted on 2017-06-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
Condition
Hypercholesterolemia
Intervention (Drug)
Placebo (for Alirocumab)
Intervention (Drug)
Alirocumab
Intervention (Drug)
Lipid-Modifying Therapy (LMT)
Lead sponsor
Sanofi (class: industry)
Collaborator
Regeneron Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct02289963
Content hash
1cf61292bbbd2827b6293dc7334e5f378a818fcf57863dcf157b8ec043c3c137